Filing Details

Accession Number:
0001437749-17-015259
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-24 18:54:46
Reporting Period:
2017-08-22
Accepted Time:
2017-08-24 17:54:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1427925 Acelrx Pharmaceuticals Inc ACRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190429 G Mark Edwards C/O Acelrx Pharmaceuticals, Inc.
351 Galveston Drive
Redwood City CA 94063
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-22 200 $2.90 115,200 No 4 P Direct
Common Stock Acquisiton 2017-08-24 4,800 $3.03 120,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct